XML 83 R16.htm IDEA: XBRL DOCUMENT
v3.20.1

Intangible Assets | 3 Months Ended
--- | ---
Mar. 31, 2020
Intangible Assets, Net (Excluding Goodwill) [Abstract] |
Intangible Assets | INTANGIBLE ASSETS The following table summarizes our intangible assets, net (in millions):
|  | March 31, 2020 |  | December 31, 2019
|  | Gross Carrying Amount |  | Accumulated Amortization |  | Foreign Currency Translation Adjustment |  | Net Carrying Amount |  | Gross Carrying Amount |  | Accumulated Amortization |  | Foreign Currency Translation Adjustment |  | Net Carrying Amount
Finite-lived assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Intangible asset - sofosbuvir |  | $ | 10,720 |  |  | $ | (4,428 | ) |  | $ | — |  |  | $ | 6,292 |  |  | $ | 10,720 |  |  | $ | (4,253 | ) |  | $ | — |  |  | $ | 6,467 |
Intangible asset - axicabtagene ciloleucel |  | 6,200 |  |  | (847 | ) |  | — |  |  | 5,353 |  |  | 6,200 |  |  | (761 | ) |  | — |  |  | 5,439 |
Intangible asset - Ranexa |  | 688 |  |  | (688 | ) |  | — |  |  | — |  |  | 688 |  |  | (688 | ) |  | — |  |  | — |
Other |  | 1,098 |  |  | (474 | ) |  | (7 | ) |  | 617 |  |  | 1,098 |  |  | (454 | ) |  | (6 | ) |  | 638 |
Total finite-lived assets |  | 18,706 |  |  | (6,437 | ) |  | (7 | ) |  | 12,262 |  |  | 18,706 |  |  | (6,156 | ) |  | (6 | ) |  | 12,544 |
Indefinite-lived assets - IPR&D |  | 1,247 |  |  | — |  |  | (7 | ) |  | 1,240 |  |  | 1,247 |  |  | — |  |  | (5 | ) |  | 1,242 |
Total intangible assets |  | $ | 19,953 |  |  | $ | (6,437 | ) |  | $ | (14 | ) |  | $ | 13,502 |  |  | $ | 19,953 |  |  | $ | (6,156 | ) |  | $ | (11 | ) |  | $ | 13,786 |
Aggregate amortization expense related to finite-lived intangible assets was $281 million and $299 million for the three months ended March 31, 2020 and 2019, respectively, and was primarily included in Cost of goods sold on our Condensed Consolidated Statements of Income. The following table summarizes the estimated future amortization expense associated with our finite-lived intangible assets as of March 31, 2020 (in millions):
Fiscal Year |  | Amount
2020 (remaining nine months) |  | $ | 844 |
2021 |  | 1,124 |
2022 |  | 1,124 |
2023 |  | 1,124 |
2024 |  | 1,124 |
Thereafter |  | 6,922 |
Total |  | $ | 12,262 |

X
- Definition The entire disclosure for all or part of the information related to intangible assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -URI http://asc.fasb.org/topic&trid=2144416 + Details
Name: | us-gaap_IntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration